YOLFTbeta
Brainsway Ltd

Brainsway Ltd

BWAY · NASDAQ · Healthcare / Medical Devices

10.11USD-0.14 (-1.37%)

Price History

Full chart

Market Stats

Previous Close10.25
Open10.31
Day Range9.71 – 10.31
52-Week Range7.14 – 17.40
Volume183.57K
Market Cap535.60M
P/E (TTM)57.87
Forward P/E17.92
EPS0.23
Dividend Yield0.00%
Beta0.08
50-Day Avg14.84
200-Day Avg13.63

About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Hadar Levy
  • Employees129
  • Headquarters16 Hartum St, Jerusalem, Israel, 9777516, USA
  • Websitehttps://www.brainsway.com

Leadership

  • Mr. Hadar LevyChief Executive Officer · b. 1974
  • Dr. David Zacut M.D.Co-Founder & Vice-Chairman · b. 1953
  • Prof. Abraham Zangen Ph.D.Co-Founder, Member of Scientific Advisory Board & Director · b. 1970
  • Mr. Ido MaromChief Financial Officer · b. 1976
  • Dr. Colleen Hanlon Ph.D.Vice President of Medical Affairs · b. 1980
  • Mr. Michael CohenVice President of US Sales
  • Dr. Yiftach Roth Ph.D.Founder & Chief Scientific Officer · b. 1971
  • Mr. Dor HagaiVice President of Operations
  • Mr. Gilead Moiseyev Ph.D.Chief Technology Officer · b. 1972
  • Mr. Menachem C. Klein Esq.VP, General Counsel & Corporate Secretary

Financials

Income Statement

Currency: USD2000-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue102.48M364.25K1.19M3.38M6.80M11.52M11.14M16.40M23.10M22.06M29.66M27.18M31.79M41.02M52.23M
Growth (%)--99.64%+226.43%+184.27%+101.18%+69.47%-3.29%+47.12%+40.89%-4.52%+34.46%-8.36%+16.96%+29.04%+27.33%
Cost of Revenue58.61M46.07K199.00K656.00K1.47M2.43M2.60M3.59M5.13M5.06M6.60M7.13M8.31M10.44M12.84M
Gross Profit43.87M318.18K990.00K2.72M5.33M9.10M8.55M12.81M17.97M17.00M23.06M20.05M23.48M30.58M39.39M
Gross Margin42.81%87.35%83.26%80.59%78.44%78.94%76.72%78.11%77.80%77.07%77.75%73.77%73.86%74.56%75.42%
Operating Expense-6.00M5.26M10.00M9.84M11.17M15.16M17.92M26.45M21.83M28.06M32.73M28.44M29.19M35.06M
Operating Income--5.68M-4.27M-7.28M-4.50M-2.07M-6.61M-5.11M-8.48M-4.83M-5.00M-12.68M-4.96M1.39M4.32M
Operating Margin--1560.22%-358.87%-215.30%-66.25%-17.95%-59.32%-31.19%-36.69%-21.89%-16.86%-46.67%-15.60%3.39%8.28%
EBITDA--5.57M-4.06M-5.68M-3.38M-1.34M-5.56M-4.40M-6.71M-2.15M-4.67M-11.45M-2.56M5.36M11.46M
EBITDA Margin--1530.22%-341.55%-168.17%-49.68%-11.66%-49.92%-26.85%-29.06%-9.75%-15.76%-42.15%-8.06%13.06%21.94%
Net Income--5.92M-7.12M-6.54M-4.09M-2.40M-7.05M-6.48M-10.33M-5.38M-6.46M-13.35M-4.20M2.92M7.63M
Net Income Margin--1624.27%-598.99%-193.64%-60.10%-20.80%-63.29%-39.51%-44.71%-24.41%-21.79%-49.12%-13.20%7.12%14.62%
R&D-5.97M3.69M6.44M4.10M3.79M5.34M6.16M7.88M5.82M6.39M7.68M6.67M7.19M9.60M
R&D as % of Total Revenue-1639.49%310.18%190.47%60.34%32.91%47.94%37.54%34.09%26.40%21.56%28.25%20.97%17.53%18.39%
Interest Expense0-283.00K525.00K37.00K61.00K134.00K395.00K506.00K319.00K141.00K68.00K298.00K1.36M2.23M
Interest Expense % of Total Revenue0.00%-23.80%15.53%0.54%0.53%1.20%2.41%2.19%1.45%0.48%0.25%0.94%3.31%4.26%

Balance Sheet

Currency: USD2000-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets77.27M10.70M17.85M25.77M22.24M19.96M27.03M23.60M38.74M34.01M75.73M64.48M62.97M94.32M112.92M
Total Liabilities34.88M2.78M3.20M10.19M9.35M9.68M14.31M16.65M14.52M14.38M18.41M19.08M21.39M32.00M39.70M
Total Equity42.39M4.90M7.83M15.58M12.89M10.29M12.72M6.95M24.22M19.63M57.33M45.40M41.58M62.31M73.22M
Cash5.45M3.32M10.68M17.26M11.36M9.17M14.51M8.97M21.67M16.96M16.92M47.58M10.52M69.34M67.70M
Total Debt-8.84K32.30K177.00K127.00K810.00K4.36M2.83M1.08M672.00K754.00K488.00K471.00K5.62M6.82M
Net Debt--3.31M-10.65M-17.08M-11.23M-8.36M-11.78M-6.13M-21.26M-16.29M-16.17M-47.09M-10.05M-63.72M-60.88M

Cash Flow

Currency: USD2000-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--5.60M-2.36M-3.79M-4.55M-2.40M-3.47M-3.77M-7.24M-1.44M884.00K-9.76M1.28M10.30M18.16M
Investing Cash Flow--2.65M-598.00K-1.08M-1.78M-393.00K-2.45M-1.14M-2.45M-2.46M-42.22M42.17M-37.41M30.31M-17.63M
Financing Cash Flow41.18M5.51M9.20M13.43M514.00K570.00K11.11M-265.00K22.47M-1.03M41.52M-1.55M-1.03M18.26M-2.23M
Capital Expenditure35.87M328.36K4.04M1.50M2.27M408.00K985.00K1.97M3.31M2.47M2.24M9.72M2.39M3.79M1.76M
Free Cash Flow--5.93M-6.41M-5.29M-6.82M-2.81M-4.45M-5.75M-10.55M-3.91M-1.35M-9.76M-1.10M6.50M16.40M
Dividends Paid----0000-------
FCF to OCF-105.86%271.14%139.44%149.87%116.99%128.41%152.27%145.71%272.01%-153.17%100.00%-85.90%63.16%90.31%
Dividend Paid to FCF----0.00%0.00%0.00%0.00%-------

Earnings

Report DateFeb 27, 2019May 29, 2019Aug 26, 2019Nov 25, 2019Mar 23, 2020Jun 24, 2020Aug 12, 2020Nov 18, 2020Mar 25, 2021May 20, 2021Aug 11, 2021Nov 17, 2021Mar 9, 2022May 11, 2022Aug 10, 2022Nov 16, 2022Mar 15, 2023May 17, 2023Aug 9, 2023Nov 15, 2023Mar 6, 2024May 8, 2024Aug 6, 2024Nov 12, 2024Mar 4, 2025May 13, 2025Aug 13, 2025Nov 11, 2025Mar 11, 2026May 13, 2026Aug 12, 2026Nov 10, 2026
EPS Estimate0.00-0.14-0.13-0.12-0.06-0.15-0.06-0.03-0.07-0.03-0.03-0.03-0.05-0.04-0.03-0.03-0.13-0.05-0.04-0.02-0.01-0.01-0.010.010.020.010.020.020.050.050.100.12
EPS Actual-0.12-0.11-0.34-0.12-0.05-0.30-0.01-0.02-0.04-0.05-0.03-0.02-0.04-0.03-0.04-0.07-0.24-0.04-0.02-0.020.010.010.010.010.040.010.030.020.060.060.14-
Surprise-21.43%-161.54%0.00%16.67%-100.00%83.33%33.33%42.86%-66.67%0.00%33.33%20.00%25.00%-33.33%-133.33%-84.62%20.00%50.00%0.00%176.00%167.00%200.00%0.00%100.00%0.00%50.00%0.00%39.91%20.00%40.00%-
Timing-Pre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap535.60M
Enterprise Value497.90M
Trailing P/E57.87
Forward P/E17.92
Price / Sales8.82
Price / Book6.83
EPS0.23
Book Value2.05
Revenue (TTM)60.70M
Gross Profit (TTM)45.72M
EBITDA8.48M
Profit Margin15.56%
Operating Margin13.98%
Return on Equity12.82%
Return on Assets4.05%
Shares Outstanding40.24M
Shares Float23.25M
Beta0.08
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 19.27
  • Strong Buy
    3
  • Buy
    1

Ownership Breakdown

Institutions
32.48%
Insiders
2.54%
Retail / Other
64.98%

Top Institutional Holders

  • Valor Management LLC
    5.31M13.22%
  • Masters Capital Management LLC
    1.50M3.73%
  • Acadian Asset Management LLC
    818.27K2.04%
  • Essex Investment Management Company, LLC
    592.61K1.47%
  • Renaissance Technologies Corp
    518.42K1.29%
  • Cresset Asset Management, LLC
    314.92K0.78%
  • Y.D. More Investments Ltd
    272.00K0.68%
  • SEI Investments Co
    226.38K0.56%
  • Legato Capital Management LLC
    197.63K0.49%
  • ARK Investment Management LLC
    193.69K0.48%
  • Eagle Global Advisors, LLC
    182.61K0.45%
  • The Goldman Sachs Group Inc
    107.71K0.27%
  • Morgan Stanley - Brokerage Accounts
    104.39K0.26%
  • Sigma Planning Corp
    100.44K0.25%
  • Two Sigma Investments LLC
    99.55K0.25%
  • Royce & Associates, LP
    97.03K0.24%

Top Fund Holders

  • Timothy Plan Israel Common Values A
    182.61K0.47%
  • ARK Israel Innovative Technology ETF
    146.85K0.37%
  • 1290 Essex Small Cap Growth I
    138.59K0.35%
  • Royce Smaller-Companies Growth Svc
    97.00K0.25%

Stock Splits

  • Mar 4, 20262:1